read more

first_img Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis Using Artificial Intelligence to Reduce Gadolinium Contrast One of the most controversial issues in radiology in recent years has been the use of… read more News | Ultrasound Imaging | March 07, 2019 Ultrasound Societies Urge FDA to Remove Black Box Warning on Contrast Agents National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black… read more Conversations with Greg Freiherr: Guerbet Unveils Portfolio of Advanced Digital SolutionsVideo Player is loading.Play VideoPlayMuteCurrent Time 0:00/Duration 5:46Loaded: 2.87%Stream Type LIVESeek to live, currently playing liveLIVERemaining Time -5:46 Playback Rate1xChaptersChaptersDescriptionsdescriptions off, selectedCaptionscaptions settings, opens captions settings dialogcaptions off, selectedAudio Trackdefault, selectedFullscreenThis is a modal window.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsReset restore all settings to the default valuesDoneClose Modal DialogEnd of dialog window.Close Modal DialogThis is a modal window. This modal can be closed by pressing the Escape key or activating the close button. Feature | Contrast Media | July 18, 2019 | By Greg Freiherr How To Manage Risk in the MR Suite Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n read more Gastrografin (diatrizoate meglumine and diatrizoate sodium solution USP) is a palatable lemon-flavored, water-soluble iodinated radiopaque contrast medium for oral or rectal administration used for radiographic examination of segments of the gastrointestinal tract and as an adjunct to contrast enhancement in CT of the torso.Bracco advises users that serious or anaphylactoid reactions that may occur with intravascular administration of radiopaque contrast agents – theoretically possible following administration by other routes. Patients at increased risk include those with a history of a previous reaction to a contrast medium, patients with a known sensitivity to iodine per se, and patients with a known clinical hypersensitivity (bronchial asthma, hay fever, and food allergies). FacebookTwitterLinkedInPrint分享 Technology | Contrast Media | August 05, 2019 Bracco Receives FDA Approval for Varibar Thin Liquid for Oral Suspension Bracco Diagnostics Inc. announced U.S. Food and Drug Administration (FDA) approval for Varibar Thin Liquid (barium… read more Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco Technology | September 30, 2008 Bracco Highlights Lemon-Flavored Gastrointestinal Contrast Agent Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.center_img Related Content News | Radiology Business | April 24, 2019 ITN Wins Jesse H. Neal Award for Best Technical Content April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H. read more News | Neuro Imaging | March 18, 2019 Non-Contrast MRI Effective in Monitoring MS Patients Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach… read more Technology | Contrast Media | July 15, 2019 FDA Approves Bayer’s Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance… read more Sponsored Content | Videos | Contrast Media | January 22, 2019 itnTV “Conversations”: Guerbet Unveils Portfolio of Advanced Digital Solutions ITN Contributing Editor Greg Freiherr speaks with Guerb read more News | Cardiovascular Ultrasound | August 07, 2019 Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for… read more Sponsored Content | Case Study | Contrast Media | January 30, 2019 Captisol-enabled Contrast Media with Reduced Renal Toxicity in Development The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodil read more last_img

Leave a Reply

Your email address will not be published. Required fields are marked *